Preventing Cardiac Complications of COVID-19 Disease with Early Acute Coronary Syndrome Therapy (C19-ACS)

This randomised controlled trial aims to determine whether acute coronary syndromes are occurring during COVID-19 disease and not being adequately diagnosed and treated.

Imperial PI Professor Prapa Kanagaratnam
Professor Darrel Francis
Trial Sponsor Imperial College London
Study type Interventional
Study status In recruitment

Find out more about this study here.

App to inform & enrol patients          Study Documents          Explainer video